Recombinant Human RANKL/TNFSF11 Protein (His Tag)(Active)
SKU: PKSH032986-100
Recombinant Human RANKL/TNFSF11 Protein (His Tag)(Active)
SKU # | PKSH032986 |
Expression Host | E.coli |
Description
Synonyms | CD254, ODF, OPGL, OPTB2, Osteoclast differentiation factor, RANKL, Receptor activator of nuclear factor kappa-B ligand, TNFSF11, hRANKL2, sOdf, tumor necrosis factor ligand superfamily member 11 |
Species | Human |
Expression Host | E.coli |
Sequence | Glu 143-Asp317 |
Accession | O14788 |
Calculated Molecular Weight | 20.7 kDa |
Observed Molecular Weight | 17 kDa |
Tag | C-His |
Bio-activity | Measure by its ability to induce osteoclast differentiation in RAW264.7 cells. The ED50 for this effect is <10 ng/mL. |
Properties
Purity | > 98 % as determined by reducing SDS-PAGE. |
Endotoxin | < 0.1 EU per μg of the protein as determined by the LAL method. |
Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
Formulation | Lyophilized from sterile PBS,pH 8.0. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
Reconstitution | Please refer to the printed manual for detailed information. |
Background
CD254, also known as RANKL, TNFSF11, TRANCE, OPGL and ODF, is a type II membrane protein of the tumor necrosis factor (TNF) superfamily, and affects the immune system and control bone regeneration and remodeling. RANKL is the ligand of nuclear factor (NF)-κB (RANK). When RANKL binds to RANK, it will undergo trimerization and then bind to an adaptor molecule TNF receptor-associated factor 6 (TRAF6). This results in the activation of several downstream signaling cascades, including the NFκB, mitogen-activated protein kinases (MAPK), activating protein 1 (AP-1), and nuclear factor of activated T cells (NFATc1), resulting in the formation of multinucleated bone-resorbing osteoclasts. RANKL is widely expressed in skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoblast, mammary gland epithelial cells, prostate and pancreas.